Rates of progression in mild cognitive impairment and early Alzheimer's disease

被引:160
|
作者
Storandt, M
Grant, EA
Miller, JP
Morris, JC
机构
[1] Washington Univ, Alzheimer Dis Res Ctr, St Louis, MO 63108 USA
[2] Washington Univ, Dept Psychol, St Louis, MO 63108 USA
[3] Washington Univ, Dept Neurol, St Louis, MO 63108 USA
[4] Washington Univ, Dept Pathol & Immunol, St Louis, MO 63108 USA
[5] Washington Univ, Div Biostat, St Louis, MO 63108 USA
关键词
D O I
10.1212/WNL.59.7.1034
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To compare rates of progression in the very mildest stages of AD, including the stage currently identified as mild cognitive impairment (MCI), and to identify predictors of those rates. Methods: Demented (n = 289) and nondemented (n = 230) individuals enrolled in longitudinal studies at an Alzheimer Disease Research Center received annual clinical and psychometric examinations for up to 20 years. In order of increasing dementia severity, demented individuals were diagnosed with incipient, very mild, or mild dementia; the incipient stage is equivalent to MCI. Outcome measures included death, nursing home placement, and psychometric scores. Results: Rate of progression increased with dementia severity as staged by the Clinical Dementia Rating at entry into the study. With respect to the dichotomous outcomes, the increase with dementia severity was more dramatic for the endpoint of nursing home entry than it was for the endpoint of death. Increased rates of cognitive decline with increased dementia severity were also obtained for psychometric scores. There was limited evidence of other predictors of progression. Conclusions: The lack of effective predictors of the rate of dementia progression extends to the very earliest stages of the disease, including what is often called MCI. A new approach to the identification of correlates of rates of progression is needed.
引用
收藏
页码:1034 / 1041
页数:8
相关论文
共 50 条
  • [1] Mild cognitive impairment and progression to dementia of Alzheimer's disease
    Quintes Steiner, Ana Beatriz
    Jacinto, Alessandro Ferrari
    De Sa Mayoral, Vania Ferreira
    Dozzi Brucki, Sonia Maria
    Citero, Vanessa De Albuquerque
    [J]. REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2017, 63 (07): : 651 - 655
  • [2] Mild cognitive impairment -: an early stage of Alzheimer's disease?
    Almkvist, O
    Basun, H
    Bäckman, L
    Herlitz, A
    Lannfelt, L
    Small, B
    Viitanen, M
    Wahlund, LO
    Winblad, B
    [J]. JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 1998, (54): : 21 - 29
  • [3] Mild cognitive impairment as an early indicator of Alzheimer's disease
    Petersen, RC
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2003, 10 (06): : 562 - 562
  • [4] Risk factors for mild cognitive impairment progression to Alzheimer's disease
    Ong, K.
    [J]. AUSTRALASIAN JOURNAL ON AGEING, 2016, 35 : 37 - 37
  • [5] Influence of Butyrylcholinesterase in Progression of Mild Cognitive Impairment to Alzheimer's Disease
    Gabriel, Antonio Jose
    Almeida, Maria Rosario
    Ribeiro, Maria Helena
    Carneiro, Diogo
    Valerio, Daniela
    Pinheiro, Ana Cristina
    Pascoal, Rui
    Santana, Isabel
    Baldeiras, Ines
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2018, 61 (03) : 1097 - 1105
  • [6] Metamemory in Mild Cognitive Impairment: relation with progression to Alzheimer's disease
    Gerardo, B.
    Duro, D.
    Nogueira, J.
    Lima, M.
    Lopes, J.
    Freitas, S.
    Santana, I.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 240 - 240
  • [7] Cognitive stimulation in mild cognitive impairment and early stage Alzheimer's disease
    Rigaud, AS
    de Rotrou, J
    Cantegreil, I
    [J]. NEUROBIOLOGY OF AGING, 2002, 23 (01) : S124 - S124
  • [8] Impact of cognitive reserve on the progression of mild cognitive impairment to Alzheimer's disease in Japan
    Osone, Akira
    Arai, Reiko
    Hakamada, Rina
    Shimoda, Kazutaka
    [J]. GERIATRICS & GERONTOLOGY INTERNATIONAL, 2015, 15 (04) : 428 - 434
  • [9] Imaging and Biomarkers in Early Alzheimer's Disease and Mild Cognitive Impairment
    Petersen, R. C.
    Jack, C. R., Jr.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 86 (04) : 438 - 441
  • [10] Normal aging, mild cognitive impairment, and early Alzheimer's disease
    Petersen, RC
    [J]. NEUROLOGIST, 1995, 1 (06) : 326 - 344